Concourse Financial Group Securities, Inc. Pro Qr Therapeutics N.V. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$1.64 - $2.24 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$1.65 - $2.39 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$1.89 - $2.85 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$1.15 - $2.21 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$1.3 - $1.77 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$1.3 - $1.77 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$1.62 - $2.32 $0 - $0
Q1 2023 May 15, 2023	BUY	$1.99 - $3.66 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$0.8 - $3.7 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$0.74 - $0.89 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$0.56 - $1.0 $0 - $0
Q1 2022 May 09, 2022	BUY	$0.9 - $8.39 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$6.58 - $8.44 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$5.16 - $8.47 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$5.75 - $7.59 $0 - $0
Q1 2021 May 13, 2021	BUY	$4.14 - $9.22 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$3.58 - $4.85 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$4.79 - $6.3 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$4.5 - $6.53 $0 - $0
Q1 2020 May 13, 2020	BUY	$5.25 - $9.9 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$5.84 - $10.51 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$5.76 - $9.44 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$9.1 - $15.55 $0 - $0
Q1 2019 May 15, 2019	BUY	$12.5 - $18.48 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$15.25 - $22.4 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$6.45 - $21.6 $0 - $0

Others Institutions Holding PRQR

# of Institutions

Shares Held

17.4M

Call Options Held

37.7K

Put Options Held

21.3K

Privium Fund Management B.V.

5.63M
Shares

$22.1 Million
2.56% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

3.63M
Shares

$14.2 Million
0.01% of portfolio
Eco R1 Capital, LLC San Francisco, CA

1.84M
Shares

$7.2 Million
0.14% of portfolio
M28 Capital Management LP Stamford, CT

1.02M
Shares

$4 Million
1.76% of portfolio
Dafna Capital Management LLC Los Angeles, CA

906K
Shares

$3.55 Million
0.42% of portfolio

View Full List

About ProQR Therapeutics N.V.

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $280M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

More about PRQR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account